Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-04-10
2000-06-13
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514243, 514247, 514248, 514249, 514300, 514302, 514303, 544184, 544236, 544264, 544278, 544280, 544179, 546113, 546115, 546118, A61K 3140, A61K 31435, C07D47104, C07D49804
Patent
active
060750162
ABSTRACT:
Novel compounds which are effective PDE IV inhibitors are disclosed. The compounds possess improved PDE IV inhibition as compared to theophylline or rolipram, with improved selectivity with regard to, e.g., PDE V inhibition. The present invention includes compounds of Formula I: ##STR1##
REFERENCES:
patent: Re31429 (1983-10-01), Tull et al.
patent: 2320654 (1943-06-01), Riester
patent: 2691654 (1954-10-01), Hitchings
patent: 2844577 (1958-07-01), Acker
patent: 2903455 (1959-09-01), Strong et al.
patent: 2956998 (1960-10-01), Baizer
patent: 2957875 (1960-10-01), Lyttle et al.
patent: 2966488 (1960-12-01), Shive et al.
patent: 3079378 (1963-02-01), Schroeder
patent: 3129225 (1964-04-01), Shapiro
patent: 3135753 (1964-06-01), Hitchings
patent: 3136771 (1964-06-01), Liechti et al.
patent: 3215696 (1965-11-01), Denayer
patent: 3225046 (1965-12-01), Zwahlen
patent: 3262929 (1966-07-01), Okubu et al.
patent: 3470164 (1969-09-01), Takamatsu
patent: 3491091 (1970-01-01), Berger
patent: 3491106 (1970-01-01), Freyermuth
patent: 3494919 (1970-02-01), Collins et al.
patent: 3516997 (1970-06-01), Takano et al.
patent: 3541100 (1970-11-01), Ramirez et al.
patent: 3551554 (1970-12-01), Herschler
patent: 3574218 (1971-04-01), Hideg et al.
patent: 3586670 (1971-06-01), Brenneisen
patent: 3590029 (1971-06-01), Koch
patent: 3626018 (1971-12-01), Taylor
patent: 3636039 (1972-01-01), Gruenman et al.
patent: 3647812 (1972-03-01), Smith
patent: 3658799 (1972-04-01), Eardley
patent: 3666769 (1972-05-01), Jones
patent: 3669979 (1972-06-01), Freyermuth
patent: 3674781 (1972-07-01), Schinzel et al.
patent: 3681328 (1972-08-01), Kurita
patent: 3686238 (1972-08-01), Zaffaroni
patent: 3706834 (1972-12-01), Scheilenbaum et al.
patent: 3923833 (1975-12-01), Gruenman et al.
patent: 3962452 (1976-06-01), Evans et al.
patent: 4020165 (1977-04-01), Hubbard
patent: 4025636 (1977-05-01), Dunwell et al.
patent: 4025637 (1977-05-01), Dunwell
patent: 4107306 (1978-08-01), Voorhees
patent: 4146721 (1979-03-01), Rainer
patent: 4167628 (1979-09-01), Kormany
patent: 4233303 (1980-11-01), Bergstrand et al.
patent: 4241063 (1980-12-01), Naito et al.
patent: 4241168 (1980-12-01), Arai
patent: 4308278 (1981-12-01), Schneider et al.
patent: 4361699 (1982-11-01), Rasmusson et al.
patent: 4407802 (1983-10-01), Graham et al.
patent: 4416892 (1983-11-01), Dawson
patent: 4454138 (1984-06-01), Goring
patent: 4469698 (1984-09-01), Philippossian et al.
patent: 4495195 (1985-01-01), Beck et al.
patent: 4616020 (1986-10-01), Furrer et al.
patent: 4652654 (1987-03-01), Verga et al.
patent: 4684656 (1987-08-01), Atwal
patent: 4684728 (1987-08-01), Mohring
patent: 4710503 (1987-12-01), Hofer
patent: 4732978 (1988-03-01), Kreft et al.
patent: 4755517 (1988-07-01), Bruns et al.
patent: 4757124 (1988-07-01), Koyanagi
patent: 4769377 (1988-09-01), Snyder et al.
patent: 4770990 (1988-09-01), Nakamura
patent: 4775695 (1988-10-01), Cragoe, Jr. et al.
patent: 4803216 (1989-02-01), Appleton et al.
patent: 4810719 (1989-03-01), Appleton et al.
patent: 4826868 (1989-05-01), Wachter et al.
patent: 4831152 (1989-05-01), Itoh et al.
patent: 4851321 (1989-07-01), Takagi
patent: 4868183 (1989-09-01), Kanai et al.
patent: 4874869 (1989-10-01), Ueda et al.
patent: 4883801 (1989-11-01), Nathanson
patent: 4910211 (1990-03-01), Imamura et al.
patent: 4918074 (1990-04-01), Tsuda et al.
patent: 4925847 (1990-05-01), Hofer
patent: 4965169 (1990-10-01), Hirano
patent: 4971972 (1990-11-01), Doll et al.
patent: 4981857 (1991-01-01), Daluge
patent: 4994363 (1991-02-01), Koya et al.
patent: 5010081 (1991-04-01), Hofer
patent: 5047411 (1991-09-01), Takasugi et al.
patent: 5057517 (1991-10-01), Johnston et al.
patent: 5068236 (1991-11-01), Suzuki et al.
patent: 5091431 (1992-02-01), Tulshian et al.
patent: 5098464 (1992-03-01), Barton et al.
patent: 5110818 (1992-05-01), Allgeier
patent: 5114835 (1992-05-01), Sakaoue
patent: 5116717 (1992-05-01), Matsushita
patent: 5117830 (1992-06-01), McAfee et al.
patent: 5139921 (1992-08-01), Takagi et al.
patent: 5177074 (1993-01-01), Allen et al.
patent: 5177085 (1993-01-01), Naef
patent: 5190942 (1993-03-01), Poss
patent: 5191084 (1993-03-01), Bagli et al.
patent: 5206255 (1993-04-01), Ubasawa et al.
patent: 5264589 (1993-11-01), Corey
patent: 5270206 (1993-12-01), Saccomano
patent: 5288896 (1994-02-01), Capiris et al.
patent: 5290782 (1994-03-01), Suzuki et al.
patent: 5322847 (1994-06-01), Marfat et al.
patent: 5342835 (1994-08-01), Pepin et al.
patent: 5369085 (1994-11-01), Hosokawa et al.
patent: 5424432 (1995-06-01), Fredenburgh et al.
patent: 5434150 (1995-07-01), Austel et al.
patent: 5436258 (1995-07-01), Blake et al.
patent: 5449686 (1995-09-01), Christensen, IV
patent: 5451596 (1995-09-01), Ullrich
patent: 5496853 (1996-03-01), Shiota et al.
patent: 5602157 (1997-02-01), Christensen, IV
patent: 5602173 (1997-02-01), Christensen, IV
patent: 5631260 (1997-05-01), Belardinelli et al.
patent: 5637708 (1997-06-01), Hogle et al.
patent: 5641789 (1997-06-01), Marfat
patent: 5665737 (1997-09-01), Cavalla et al.
CA Select: "Anti-Inflammatory Agents & Arthritis" Issue 7, 1996, p. 26.
CA of "1-Pharmacology", vol. 106, 1987, p. 61.
CA Selects: "Allergy & Antiallergic Agents", Issue 5, 1996, pp. 17 and 19.
CA Selects: "Allergy & Antiallergic Agents", Issue 21, 1995, p. 13.
CA Selects: Anti-Inflammatory Agents & Arthritis, Issue 23, 1995, p. 17 and 23.
CA Selects: "Anti-Inflammatory Agents & Arthritis", Issue 25, 1996, (1 page).
CA 171494, 171495 and KG-2683 of Annual Drug Data Report 1991 (1 sheet).
Ronald E. Weishaar, et al., Subclasses of Cyclic GMP-Specific phosphodiesterase and their role in regulating the effects of atrial natriuretic factor, Dept. Of Pharmacology, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Co. Hypertension, vol. 15, No. 5, May 1990.
"Differential modulation of tissue function and therapeutic potential selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes", C. David Nicholson, R.A. John Chaliss and Mohammed Shahid, 1991, Elsevier Science Publishers Ltd. (UK), TIPS 12:19-27.
"Phosphodiesterase inhibitors: new opportunities for the treatment of asthma", Theodore J. Torphy, Bradley J. Undem, Thorax 1991; 46:512-523.
"Novel phosphodiesterase inhibitors for the therapy of asthma", Theodore J. Torphy, George P. Livi and Siegfried B. Christensen, DN&P 6(4), May 1993 pp. 203-214.
"Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme", W. Joseph Thompson, Wesley L. Terasaki, Paul M. Epstein, Samuel J. Strada, Advances in Cyclic Nucleotide Research, vol. 10, 1979, pp. 69-92.
"Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle", Theodore J. Torphy, Bradley J. Undem, Lenora B. Cieslinski, Mark A. Luttmann, Martin L. Reeves and Douglas W.P. Hay, The Journal of Pharmacology and Experimental Therapeutics, 1993, vol. 265, No. 3, 1213-1223.
"The PDE IV family of calcium-independent phosphodiesterase enzymes", John A. Lowe III and John B. Cheng, Drugs of the Future, 1992, 17(9): 799-807.
"Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma?", Mark A. Giembycz, Biochemical Pharmacology, 1992, vol. 43, No. 10 pp. 2041-2051.
"Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes from cardiac muscle, arterial and airway smooth muscle", Paul J. Silver, Linda T. Hamel, Mark H. Perrone, Ros G. Bently, Cynthia R. Bushover and Dale B. Evans, European Journal of Pharmacology, 150 (1988) 85-94, Elsevier.
"Structure-Activity Relationships in a Series of 6-Thioxanthines with Bronchodilator and Coronary Dilator Properties", A.K. Armitrage, Janet Boswood and B.J. Large, Brit. J. Pharma. 1961, 17:196-207.
"The Synthesis of Some 6 Thioxanthines", K.R.H. Wooldrige and R. Slack, J. Chem. Soc. 1962, Annex IV:1863-1868.
Chemical Abstracts, vol. 85, No. 1 (Jul. 9, 1976) 5692s (Enoki).
Chemical Abstracts, vol. 84, No. 25 (Jun. 21, 1976) 180299v (Enoki).
Chemical Abstracts, vol. 86, No. 7 (Feb. 14
Cavalla David
Chasin Mark
Gehrig Andre
Hofer Peter
Wintergerst Peter
Euro-Celtique S.A.
McKane Joseph
LandOfFree
6,5-fused aromatic ring systems having enhanced phosphodiesteras does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6,5-fused aromatic ring systems having enhanced phosphodiesteras, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6,5-fused aromatic ring systems having enhanced phosphodiesteras will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2068865